Cryo-Cell International, Inc. (CCEL) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryo-Cell International, Inc. on September 10, 2026. The filing addresses corporate governance matters regarding the scheduling of the company's 2026 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on administrative and governance events rather than financial performance.
Material Changes
There are no material changes to financial operations or business strategy reported in this document. The primary event is the formal announcement of the Annual Meeting schedule and the associated record date.
Guidance, Outlook, and Management Commentary
Management has fixed the following dates for the 2026 Annual Meeting of Stockholders:
- Meeting Date: October 27, 2026
- Record Date: September 21, 2026 (for determining stockholders entitled to notice and vote)
Deadlines for stockholders to propose business or nominate directors for the Annual Meeting were July 27, 2026, as per the Company's Bylaws. No forward-looking financial guidance or risk factors were disclosed in this specific filing.
Key Facts for Investor Verification
- Verify stock ownership status as of the September 21, 2026 record date to confirm voting eligibility.
- Confirm the final agenda for the October 27, 2026 Annual Meeting once the proxy statement is released.
- Note that the deadline for submitting shareholder proposals or director nominations for this meeting has passed.